A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19

Autor: Nicole C.E. Aloia, Betty Jorgenson, Sarah J. Bell, Molly J. Destro Borgen, Mary A. Gilmer, Jennifer J. Larsen, Damian J. Paulson, Christopher R. Gulden, Larry Lutwick, Daniel C. Whipple, Ravindra Ganesh, Sara N. Hanson, Kevin I. Reid, Brian D. Kennedy, W. Charles Huskins, Tammy A. Jackson, Richard J. Horecki, Wilford L. Ramsey, Muhanad Mohamed, Gokhan Anil, Colleena N. Ness, Edward J. Malone, Kevin L. Epps, Sarah R. Lessard, Sara Ausman, Rachel K. Bishop, Susan M. Flaker, Sidna M. Tulledge-Scheitel, Taunya J. Rau-Kane, Paschalis Vergidis, Brian B Kottke, Laura H. Hopkins, Perry W. Sweeten, Mary K. Klingsporn, Ala S. Dababneh, Alexander Heyliger, Raymund R. Razonable, Caroline G. Wilker, Janki Patel, Donna J. Springer, Ryan R. Johnson, Shelly M. Olson, Ryan J. Anderson, Jill M. Smith, Dennis M. Bierle, Ivana N. Micallef, Carl H. Cramer, Raj Palraj, Darcie E. Moehnke, Margaret T. Peinovich, Jennifer A. Matoush, Amber N. Derr, Erin C. Skold, Laurie A. Spielman, Eric O. Gomez Urena, Karen J. Reinschmidt, Marcie Billings, Leigh L. Speicher, Tracy L. Culbertson, Lori L Arndt, Lex D. Hokanson, Maria Teresa Seville, Cory Kudrna, Jenna R. Herzog, David M. Phelan, Bipinchandra Hirisave Krishna, Richard F. Arndt, Robert Orenstein, Jennifer M. Tempelis, Tamara L. Haack

Publikováno v: Mayo Clinic Proceedings. 96:1250-1261

The administration of spike monoclonal antibody treatment to patients with mild to moderate COVID-19 is very challenging. This article summarizes essential components and processes in establishing an effective spike monoclonal antibody infusion progr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee23db29642da4efce09b0f57aa769b4
https://doi.org/10.1016/j.mayocp.2021.03.010